Patrizia Mazzucato

Patrizia Mazzucato is a Scientist at Vertex Pharmaceuticals since April 2023 and a Senior Associate Scientist I at Editas Medicine since January 2020, where responsibilities include developing an iPSC engineering and cloning platform for CRISPR cell medicines and optimizing cGMP processes for clinical compatibility. Prior experience includes serving as a Senior Research Associate at the Broad Institute of MIT and Harvard, focusing on gene-targeting experiments using CRISPR-Cas9 for human stem cell lines, and training others in sterile culture techniques. Mazzucato began research work at the Massachusetts Institute of Technology in various roles, contributing to DNA repair assays and high-throughput analyses. Educational credentials include a Master's Degree in Biological Sciences from Università degli Studi di Padova and Università degli Studi di Ferrara.